Editorial Comment

These authors completed the first randomized, controlled trial demonstrating a benefit to partial prostate ablation in early stage prostate cancer, now with 4 years of followup. While we have traditionally looked for a benefit in cancer specific or overall survival before concluding that a cancer treatment is effective, this is hard to demonstrate even for prostatectomy for this disease. Thus, a reduction in the burden of care (ie radical whole gland prostate therapy) would also be beneficial as it reduces the cost and side effects of treatment.
Source: The Journal of Urology - Category: Urology & Nephrology Authors: Tags: Adult Urology Source Type: research